Decibel Therapeutics, Inc. Shareholders' Equity
Decibel Therapeutics, Inc. had Shareholders' Equity of $53.31 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-08-11
- 2023-06-30: Stockholders' Equity Attributable to Parent $53.31M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $69.84M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $81.79M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $96.81M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-06-30 | $53.31M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $69.84M 10-Q · filed 2023-08-11 |
| 2022-12-31 | $81.79M 10-Q · filed 2023-08-11 |
| 2022-09-30 | $96.81M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $111.86M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $128.12M 10-Q · filed 2023-08-11 |
| 2021-12-31 | $141.69M 10-Q · filed 2023-08-11 |
| 2021-09-30 | $154.16M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $169.41M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $180.27M 10-Q · filed 2022-11-09 |
| 2020-12-31 | -$54.78M 10-K · filed 2023-03-14 |
| 2020-09-30 | -$147.64M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$140.72M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$133.10M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$121.80M 10-K · filed 2022-03-18 |